УСПЕХИ В РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ КОНТРОЛЯ НАД АЛКОГОЛЬНОЙ ПРОДУКЦИЕЙ, 2010–2019 ГГ
A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action Plan ...to Reduce the Harmful Use of Alcohol 2012–2020 (EAPA), including the current status of implementation of the five action areas of the WHO-led SAFER initiative:
Strengthen restrictions on alcohol availability;
Advance and enforce drink–driving countermeasures;
Facilitate access to screening, brief interventions and treatment;
Enforce bans or comprehensive restrictions on alcohol advertising, sponsorship and promotion; and
Raise prices on alcohol through excise taxes and pricing policies.
more
The European Union Agency for Fundamental Rights (FRA) collected evidence through field missions and from other sources reporting on the situation in March, May and October 2022.
In parallel, it launched a large-scale online survey of those fleeing Ukraine. This aimed to gather personal experiences... of their journey to, arrival in and settling in the EU. The survey covered displaced people, including many children, in the 10 EU Member States hosting large numbers of people registered for temporary protection.
more
Infection prevention and control measures for Ebola virus disease
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure on health services.
This document builds upon exi...sting ECDC documents, including guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV, a rapid risk assessment: outbreak of novel coronavirus disease – 5th update, a technical report on the use of evidence in decision-making during public health emergencies, and a guidance document on community engagement for public health events caused by communicable disease threats in the EU/EEA.
more
Guiding principles for reuse are:
Respirators which have been visibly contaminated (e.g. during procedure at intubated patients, such as suction cleaning of airways, taking probes, extubation attempts, etc.) or are damaged or not fitting, should be discarded and cannot be taken for re-use or de...contamination procedures.
Respirators may be protected by a medical face mask in order to prevent soiling.
Use of new ‘expired respirators’ (manufacturers expiry date) is possible if they were properly stored until use.
more
Russia's unprovoked invasion of Ukraine, a country known as the 'breadbasket of Europe', is raising fears of a
global food crisis, further exacerbating existing food security challenges worldwide. Much depends on the
response of the international community, including the EU, to a number of rapidly... evolving scenarios.
more
This leaflet provides support and advice for adults who are recovering from COVID-19. It can be used by individuals after hospitalization from the illness and those in the community who did not need hospitalization. The leaflet can complement care received from health care professionals. This is the... second edition of the leaflet that was originally published mid 2020 that includes updates to sections and new topics, encompassing what we have learnt about the condition and recovery in the last year. The leaflet was written by rehabilitation professionals in consultation with people recovering from COVID-19. Although references are not shown for ease of reading, the advice is evidence-based. There is still much we don’t know about post-COVID-19 recovery, and evidence is fast emerging.
Available in different languages
more
The Rehabilitation self-management leaflet provides basic exercises and advice for adults who have been severely unwell and admitted to the hospital with COVID-19. The leaflet assist in self-rehabilitation and recovery management, addressing specifically the common residual COVID-19 symptoms, specif...ically breathlessness, starting exercise, getting back to functional activities, mental health and post intubation symptoms such as voice weakness, eating, drinking and attention and memory deficits.
Available in different languages
more
A Snapshot of European Collection Schemes
Настоящий документ был опубликован в рамках инициативы Международного партнерства за
права человека (МППЧ) и его партнеров по мониторингу и документированию воз...ействия на
права человека мер, принимаемых правительствами в ответ на пандемию Covid-19 в Центральной
Азии и других странах бывшего Советского Союза. (the impact of COVID-19 on human rigths in central asia)
more
Dieses Handbuch bietet einen Überblick über das geltende Recht im Zusammenhang mit Asyl, Grenzmanagement und Einwanderung und umfasst sowohl das Recht der Europäischen Union als auch die Europäische Menschenrechtskonvention (EMRK). Im Handbuch wird die Situation derjenigen Ausländer untersucht,... die in der EU in der Regel als Drittstaatsangehörige bezeichnet werden. Mit diesem Handbuch sollen unter anderem Nichtregierungsorganisationen (NRO) und andere Einrichtungen unterstützt werden, die nicht auf den Bereich Asyl, Grenzen und Einwanderungsrecht spezialisiert sind und die sich möglicherweise mit rechtlichen Fragen in diesem Bereich auseinandersetzen müssen.
Für andere Sprachversionen siehe auch unter http://fra.europa.eu/de/publication/2013/handbuch-zu-den-europarechtlichen-grundlagen-im-bereich-asyl-grenzen-und-migration
more
Die Verordnung (EU) Nr. 604/2013 des Europäischen Parlaments und des Rates vom 26. Juni 2013 ist eine Verordnung der Europäischen Union, nach der der Mitgliedstaat bestimmt wird, der für die Durchführung eines Asylverfahrens zuständig ist. Die Verordnung tritt an die Stelle der Dublin-II-Verord...nung und wird auch Dublin-III-Verordnung genannt. Sie ist am 19. Juli 2013 in Kraft getreten und ist ihrem Art. 49 zufolge ab dem 1. Januar 2014 unmittelbar anzuwenden.
Andere Sprachversionen verfügbar siehe http://eur-lex.europa.eu/legal-content/DE/TXT/?qid=1445167987946&uri=CELEX:32013R0604
more
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...e measures, including policies, interventions and communications.
more
Dieser Bericht behandelt Rechtsvorschriften und Verfahren im Zusammenhang mit dem Zugang von Migranten in einer irregulären Situation zu medizinischer Versorgung in zehn EU-Mitgliedstaaten. Er konzentriert sich auf Migranten in einer irregulären Situation, nämlich jene die Einreise- oder Aufenent...haltsbedingungen nicht erfüllen.
Für Versionen in Französisch, Polnisch und Schwedisch siehe auch http://fra.europa.eu/de/publication/2012/migranten-einer-irregulren-situation-zugang-zu-medizinischer-versorgung-zehn
more
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...oir of the infections. There is a strong need to control AAT, as is claimed by the European Commission in a recent document on the reservation of antimicrobials for human use. Control of AAT is considered part of the One Health approach established by the FAO program against African Trypanosomiasis. Under the umbrella of the One Health concepts, in this work, by analyzing the pharmacological properties of the therapeutic options against Trypanosoma brucei spp., we underline the need for clearer and more defined guidelines in the employment of drugs designed for HAT and AAT. Essential requirements are addressed to meet the challenge of drug use and drug resistance development. This approach shall avoid inter-species cross-resistance phenomena and retain drugs therapeutic activity.
more
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...s of the clinical trials of fexinidazole. The screening of the Drugs for Neglected Diseases initiative (DNDi) HAT-library by the Swiss TPH had singled out fexinidazole, originally developed by Hoechst (now Sanofi), as the most promising of a series of over 800 nitroimidazoles and related molecules. In cell culture, fexinidazole has an IC50 of around 1 µM against Trypanosoma brucei and is more than 100-fold less toxic to mammalian cells. In the mouse model, fexinidazole cures both the first, haemolymphatic, and the second, meningoencephalitic stage of the infection, the latter at 100 mg/kg twice daily for 5 days. In patients, the clinical trials managed by DNDi and supported by Swiss TPH mainly conducted in the Democratic Republic of the Congo demonstrated that oral fexinidazole is safe and effective for use against first- and early second-stage sleeping sickness. Based on the positive opinion issued by the European Medicines Agency in 2018, the WHO has released new interim guidelines for the treatment of HAT including fexinidazole as the new therapy for first-stage and non-severe second-stage sleeping sickness caused by Trypanosoma brucei gambiense (gHAT). This greatly facilitates the diagnosis and treatment algorithm for gHAT, increasing the attainable coverage and paving the way towards the envisaged goal of zero transmission by 2030.
more